News Agency
Men's Weekly

Patient Enrollment Completed for the Phase 3 Trial of Boan Biotech's Aflibercept Intravitreous Injection in China

  • Written by PR Newswire

YANTAI, China, March 13, 2023 /PRNewswire/ -- Luye Pharma Group today announced that patient enrollment has been completed for the Phase 3 clinical study (comparative clinical study of efficacy and safety) of BA9101 (Aflibercept Intravitreous Injection) in China. This is an investigational ophthalmic drug developed by the group's subsidiary...

Read more: Patient Enrollment Completed for the Phase 3 Trial of Boan Biotech's Aflibercept Intravitreous...

How Often Should You Visit the Dentist? Here’s What Experts Say

When it comes to having a healthy smile, perhaps the most frequently asked question is, "How frequently should I go to the dentist?" Although there's a rule of thumb that says visit the dentist every six months, the truth isn't... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion